Abstract
Glucose is the main substrate for energy metabolism of the brain, and the regional cerebral metabolic rate is directly related to regional brain activity. Therefore, the measurement of regional glucose metabolism is of great importance for the assessment of regional normal function and of pathological changes. Quantitation of glucose metabolism by PET is based on the 2-deoxyglucose method developed by Sokoloff and colleagues: F18-labelled deoxyglucose (FDG) is transported into the brain and phosphorylated, but cannot be further metabolised and therefore is accumulated intracellularly. The concentration of the tracer can be measured three dimensionally by PET, and together with the arterial tracer concentration, the kinetics of glucose uptake can be assessed and the regional cerebral metabolic rate of glucose (rCMRGlc) can be calculated.
rCMRGlc is high in cortex and grey matter structures and low in white matter, but there are significant differences among various regions. Metabolic rate is slightly reduced with ageing and changed by sleep, dream, and functional activation. CMRGlc is significantly affected in pathological states and the regional and global changes are important for assessing severity of disorders and for differential diagnosis of diseases of the brain. Therefore, FDG-PET has still great importance in brain research and many applications in clinical neurology.
Wolf-Dieter Heiss was supported by the WDH Foundation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blomqvist G, Stone-Elander S, Halldin C, Roland PE, Widen L, Lindqvist M, Swahn CG, Langström B, Wiesel FA (1990) Positron emission tomographic measurements of cerebral glucose utilization using [1–11 C]D-glucose. J Cereb Blood Flow Metab 10(4):467–483
Bohnen NI, Djang DS, Herholz K, Anzai Y, Minoshima S (2012) Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med 53(1):59–71
Catana C, Drzezga A, Heiss WD, Rosen BR (2012) PET/MRI for neurologic applications. J Nucl Med 53:1916–1925
Chetelat G, Landeau B, Salmon E, Yakushev I, Bahri MA, Mezenge F, Perrotin A, Bastin C, Manrique A, Scheurich A, Scheckenberger M, Desgranges B, Eustache F, Fellgiebel A (2013) Relationships between brain metabolism decrease in normal aging and changes in structural and functional connectivity. Neuroimage 76:167–177
Chierichetti F, Pizzolato G (2012) F-18-Fdg-Pet/Ct. Q J Nucl Med Mol Imaging 56(2):138–150
Choo IH, Ni RQ, Scholl M, Wall A, Almkvist O, Nordberg A (2013) Combination of F-18-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer’s disease in mild cognitive impairment patients. J Alzheimers Dis 33(4):929–939
Chugani HT, Phelps ME, Mazziotta JC (1987) Positron emission tomography study of human brain functional development. Ann Neurol 22:487–497
Clarke DD, Sokoloff L (1999) Circulation and energy metabolism of the brain. In: Siegel G, Agranoff B, Albers RW, Fisher S (eds) Basic neurochemistry: molecular, cellular, and medical aspects, 6th edn. Lippincott-Raven, Philadelphia, pp 637–669
Drzezga A (2009) Diagnosis of Alzheimer’s disease with [18F]PET in mild and asymptomatic stages. Behav Neurol 21(1–2):101–115
Duara R, Grady C, Haxby J, Ingvar D, Sokoloff L, Margolin RA, Manning RG, Cutler NR, Rapoport SI (1984) Human brain glucose utilization and cognitive function in relation to age. Ann Neurol 16:702–713
Fox PT, Raichle ME, Mintun MA, Dence C (1988) Nonoxidative glucose consumption during focal physiologic neural activity. Science 241:462–464
Hawkins RA, Phelps ME, Huang SC, Kuhl DE (1981) Effect of ischemia on quantification of local cerebral glucose metabolic rate in man. J Cereb Blood Flow Metab 1:37–51
Heiss W-D (2009a) The potential of PET/MR for brain imaging. Eur J Nucl Med Mol Imaging 36:105–112
Heiss W-D, Raab P, Lanfermann H (2011) Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med 52(10):1585–1600
Heiss WD (2009b) WSO Leadership in Stroke Medicine Award Lecture Vienna, September 26, 2008: functional imaging correlates to disturbance and recovery of language function. Int J Stroke 4(2):129–136
Heiss WD, Habedank B, Klein JC, Herholz K, Wienhard K, Lenox M, Nutt R (2004) Metabolic rates in small brain nuclei determined by high-resolution PET. J Nucl Med 45(11):1811–1815
Heiss WD, Pawlik G, Herholz K, Wagner R, Göldner H, Wienhard K (1984) Regional kinetic constants and CMR glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab 4(2):212–223
Heiss WD, Pawlik G, Herholz K, Wagner R, Wienhard K (1985) Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming. Brain Res 327(1–2):362–366
Heiss WD, Zimmermann-Meinzingen S (2012) PET imaging in the differential diagnosis of vascular dementia. J Neurol Sci 322(1–2):268–273
Herholz K, Herscovitch P, Heiss WD (2004) NeuroPET – positron emission tomography in neuroscience and clinical neurology. Springer, Berlin
Herholz K, Langen KJ, Schiepers C, Mountz JM (2012) Brain tumors. Semin Nucl Med 42(6):356–370
Hsieh TC, Lin WY, Ding HJ, Sun SS, Wu YC, Yen KY, Kao CH (2012) Sex- and age-related differences in brain FDG metabolism of healthy adults: an SPM analysis. J Neuroimaging 22(1):21–27
Jones T, Rabiner EA, PET Research Advisory Company (2012) The development, past achievements, and future directions of brain PET. J Cereb Blood Flow Metab 32(7):1426–1454
Kalpouzos G, Chetelat G, Baron JC, Landeau B, Mevel K, Godeau C, Barre L, Constans JM, Viader F, Eustache F, Desgranges B (2009) Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 30(1):112–124
Kety SS, Schmidt CF (1948) The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 27(4):476–483
Kuhl DE, Metter EJ, Riege WH, Phelps ME (1982) Effects of human aging on patterns of local cerebral glucose utilization determined by the (18F)fluorodeoxyglucose method. J Cereb Blood Flow Metab 2:163–171
Kuwabara H, Evans AC, Gjedde A (1990) Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurement with (18) fluorodeoxyglucose. J Cereb Blood Flow Metab 10:180–189
Laughlin SB, Attwell D (2001) The metabolic cost of neural information: from fly eye to mammalian cortex. In: Frackowiak RSJ, Magistretti PJ, Shulman RG, Altman JS, Adams M (eds) Neuroenergetics: relevance for functional brain imaging. HFSP – Workshop XI, Strasbourg, pp 54–64
Magistretti PJ, Pellerin L, Martin J-L (1995) Brain energy metabolism: an integrated cellular perspective. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 657–670
Mangold R, Sokoloff L, Conner E, Kleinerman J, Therman PO, Kety SS (1955) The effects of sleep and lack of sleep on the cerebral circulation and metabolism of normal young men. J Clin Invest 34(7, Part 1):1092–1100
Mintun MA, Lundstrom BN, Snyder AZ, Vlassenko AG, Shulman GL, Raichle ME (2001) Blood flow and oxygen delivery to human brain during functional activity: theoretical modeling and experimental data. Proc Natl Acad Sci U S A 98(12):6859–6864
Nofzinger EA, Mintun MA, Wiseman M, Kupfer DJ, Moore RY (1997) Forebrain activation in REM sleep: an FDG PET study. Brain Res 770(1–2):192–201
Pakkenberg B, Gundersen HJ (1997) Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 384(2):312–320
Pardridge WM, Oldendorf WH (1977) Transport of metabolic substrates through the blood–brain barrier. J Neurochem 28(1):5–12
Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3(1):1–7
Pawlik G, Heiss WD (1989) Positron emission tomography and neuropsychological function. In: Bigler ED, Yeo RA, Turkheimer E (eds) Neuropsychological function and brain imaging. Plenum Publ. Corp, New York, pp 65–138
Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6:371–388
Phelps ME, Mazziotta JC, Kuhl DE (1981) Metabolic response of the brain to visual and auditory stimulation: studies in man. Stroke 12:122–122
Portnow LH, Vaillancourt DE, Okun MS (2013) The history of cerebral PET scanning from physiology to cutting-edge technology. Neurology 80(10):952–956
Raichle ME, Larson KB, Phelps ME, Grubb RL, Welch MJ, Ter-Pogossian MM (1975) In vivo measurement of brain glucose transport and metabolism employing glucose – 11 C. Am J Physiol 228:1936–1948
Reivich M, Alavi A, Wolf A, Fowler J, Russell J, Arnett C, Macgregor RR, Shiue CY, Atkins H, Anand A, Dann R, Greenberg JH (1985) Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for (18F) fluorodeoxyglucose and (11 C)deoxyglucose. J Cereb Blood Flow Metab 5:179–192
Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som P, Sokoloff L (1979) The (18F)fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44:127–137
Siesjö BK (1978) Brain energy metabolism. Wiley, New York
Silverman DHS, Melega WP (2003) Molecular imaging of biologic processes with PET: evaluation biologic bases of cerebral function. In: Phelps ME (ed) PET. Molecular imaging and its biological applications. Springer, New York, pp 509–583
Sokoloff L (1989) Circulation and energy metabolism of the brain. In: Siegel G, Agranoff B, Albers RW, Molinoff P (eds) Basic neurochemistry: molecular, cellular, and medical aspects. Raven Press, New York
Sokoloff L (1999) Energetics of functional activation in neural tissues. Neurochem Res 24(2):321–329
Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The (14 C)-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897–916
Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME (2010) Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci U S A 107(41):17757–17762
Wienhard K, Pawlik G, Herholz K, Wagner R, Heiss WD (1985) Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures. J Cereb Blood Flow Metab 5(1):115–125
Wu HM, Bergsneider M, Glenn TC, Yeh E, Hovda DA, Phelps ME, Huang SC (2003) Measurement of the global lumped constant for 2-deoxy-2-[18F]fluoro-D-glucose in normal human brain using [15O]water and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography imaging. A method with validation based on multiple methodologies. Mol Imaging Biol 5(1):32–41
Wyss MT, Jolivet R, Buck A, Magistretti PJ, Weber B (2011) In vivo evidence for lactate as a neuronal energy source. J Neurosci 31(20):7477–7485
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Heiss, WD. (2014). Cerebral Glucose Metabolism. In: Dierckx, R., Otte, A., de Vries, E., van Waarde, A., Luiten, P. (eds) PET and SPECT of Neurobiological Systems. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-42014-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-42014-6_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-42013-9
Online ISBN: 978-3-642-42014-6
eBook Packages: MedicineMedicine (R0)